GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Debt-to-EBITDA

Biogena Group Invest AG (WBO:BIO) Debt-to-EBITDA : 0.00 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Biogena Group Invest AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.00 Mil. Biogena Group Invest AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.00 Mil. Biogena Group Invest AG's annualized EBITDA for the quarter that ended in Jan. 2024 was €0.18 Mil. Biogena Group Invest AG's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Biogena Group Invest AG's Debt-to-EBITDA or its related term are showing as below:

WBO:BIO's Debt-to-EBITDA is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 2.12
* Ranked among companies with meaningful Debt-to-EBITDA only.

Biogena Group Invest AG Debt-to-EBITDA Historical Data

The historical data trend for Biogena Group Invest AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Debt-to-EBITDA Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Debt-to-EBITDA
- - - -

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Debt-to-EBITDA - - - -

Competitive Comparison of Biogena Group Invest AG's Debt-to-EBITDA

For the Packaged Foods subindustry, Biogena Group Invest AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Debt-to-EBITDA Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Debt-to-EBITDA falls into.



Biogena Group Invest AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Biogena Group Invest AG's Debt-to-EBITDA for the fiscal year that ended in Jan. 2024 is calculated as

Biogena Group Invest AG's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Jan. 2024) EBITDA data.


Biogena Group Invest AG  (WBO:BIO) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Biogena Group Invest AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.